{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:43:48Z","timestamp":1777657428280,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","radiographyonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiography"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.radi.2024.03.015","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T11:01:05Z","timestamp":1714215665000},"page":"986-994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictive value of magnetic resonance imaging diffusion parameters using artificial intelligence in low-and intermediate-risk prostate cancer patients treated with stereotactic ablative radiotherapy: A pilot study"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0567-3744","authenticated-orcid":false,"given":"A.","family":"Kedves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Akay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Akay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kisiv\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Glav\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7329-3252","authenticated-orcid":false,"given":"\u00c1.","family":"Miovecz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9245-4728","authenticated-orcid":false,"given":"Z.","family":"Kisander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-3292","authenticated-orcid":false,"given":"A.","family":"L\u0151rincz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sz\u0151ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"S\u00e1nta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Freihat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9615-1740","authenticated-orcid":false,"given":"D.","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lakosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.radi.2024.03.015_bib1","first-page":"2225","volume":"126","author":"Henley","year":"2021","journal-title":"National cancer statistics"},{"key":"10.1016\/j.radi.2024.03.015_bib2","first-page":"1","article-title":"The impact of life expectancy on cost-effectiveness of treatment options for clinically localized prostate cancer","volume":"205","author":"Naser-Tavakolian","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.radi.2024.03.015_bib3","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1007\/s00345-022-04144-7","article-title":"Treatment options for low-risk prostate cancer","volume":"40","author":"Song","year":"2022","journal-title":"World J Urol Germany"},{"key":"10.1016\/j.radi.2024.03.015_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2022.02.016","article-title":"Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer","volume":"169","author":"Greco","year":"2022","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.radi.2024.03.015_bib5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.euo.2019.09.006","article-title":"Early tolerance and tumor control outcomes with high-dose ultrahypofractionated radiation therapy for prostate cancer","volume":"3","author":"Zelefsky","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.radi.2024.03.015_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/1557988320927241","article-title":"Stereotactic body radiotherapy for prostate cancer","volume":"14","author":"Parikh","year":"2020","journal-title":"Am J Mens Health"},{"issue":"13","key":"10.1016\/j.radi.2024.03.015_bib7","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/cncr.31551","article-title":"Annual report to the nation on the status of cancer, part I: national cancer statistics","volume":"124","author":"Cronin","year":"2018","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.radi.2024.03.015_bib8","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1158\/1078-0432.CCR-14-1191","article-title":"Emerging treatment paradigms in radiation oncology","volume":"21","author":"Le","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"10185","key":"10.1016\/j.radi.2024.03.015_bib9","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet [Internet]"},{"issue":"25","key":"10.1016\/j.radi.2024.03.015_bib10","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET Phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.radi.2024.03.015_bib11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic body radiation therapy for localized prostate cancer: A systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.radi.2024.03.015_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.radi.2024.03.015_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5114\/jcb.2021.105846","article-title":"High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center","volume":"13","author":"Johansson","year":"2021","journal-title":"J Contemp Brachytherapy"},{"issue":"1","key":"10.1016\/j.radi.2024.03.015_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/13685538.2021.1948992","article-title":"The efficacy and tolerability of ultra-hypofractionated radiotherapy in low-intermediate risk prostate cancer patients: single center experience","volume":"24","author":"Din\u00e7er","year":"2021","journal-title":"Aging Male"},{"issue":"2","key":"10.1016\/j.radi.2024.03.015_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.8006","article-title":"Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer","volume":"2","author":"Kishan","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.radi.2024.03.015_bib16","first-page":"1","article-title":"Stereotactic body radiation therapy for prostate cancer-a review","volume":"6","author":"Haque","year":"2017","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"10.1016\/j.radi.2024.03.015_bib17","first-page":"38","article-title":"Stereotactic ablative body radiotherapy for intermediate- or high-risk prostate cancer","volume":"26","author":"Loblaw","year":"2020","journal-title":"Cancer J (United States)"},{"issue":"3","key":"10.1016\/j.radi.2024.03.015_bib18","first-page":"391","volume":"76","author":"Moon","year":"2020","journal-title":"Health Research Alliance"},{"issue":"5","key":"10.1016\/j.radi.2024.03.015_bib19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ijrobp.2019.08.041","article-title":"Quality of life outcomes after stereotactic ablative radiation therapy (SABR) versus standard of care treatments in the oligometastatic setting: A secondary analysis of the SABR-COMET randomized trial","volume":"105","author":"Olson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys [Internet]"},{"key":"10.1016\/j.radi.2024.03.015_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2019.11.017","article-title":"Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy","volume":"144","author":"Alayed","year":"2020","journal-title":"Radiother Oncol [Internet]"},{"issue":"10","key":"10.1016\/j.radi.2024.03.015_bib21","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s11255-022-03306-1","article-title":"Comparative results of focal-cryoablation and stereotactic body radiotherapy in the treatment of unilateral, low-to-intermediate-risk prostate cancer","volume":"54","author":"Monaco","year":"2022","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"10.1016\/j.radi.2024.03.015_bib22","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.21873\/anticanres.11258","article-title":"Clinical significance of the apparent diffusion coefficient ratio in prostate cancer treatment with intensity-modulated radiotherapy","volume":"36","author":"Yamaguchi","year":"2016","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.radi.2024.03.015_bib23","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.brachy.2017.07.008","article-title":"Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy","volume":"16","author":"Hegde","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radi.2024.03.015_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2022.06.011","article-title":"The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy","volume":"173","author":"Onal","year":"2022","journal-title":"Radiother Oncol [Internet]"},{"issue":"12","key":"10.1016\/j.radi.2024.03.015_bib25","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1007\/s00330-020-07008-z","article-title":"Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI","volume":"30","author":"Arif","year":"2020","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.radi.2024.03.015_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2002-3-9-research0048","article-title":"A new non-linear normalization method for reducing variability in DNA microarray experiments","volume":"3","author":"Workman","year":"2002","journal-title":"Genome Biol"},{"key":"10.1016\/j.radi.2024.03.015_bib27","doi-asserted-by":"crossref","first-page":"97813","DOI":"10.1109\/ACCESS.2021.3092368","article-title":"Selecting Relevant Genes from Microarray Datasets Using a Random Forest Model","volume":"9","author":"Xia","year":"2021","journal-title":"IEEE Access"},{"key":"10.1016\/j.radi.2024.03.015_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00272","article-title":"Radiomic machine-learning classifiers for prognostic biomarkers of head and neck cancer","volume":"5","author":"Parmar","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.radi.2024.03.015_bib29","series-title":"Application and Clinical Value of Machine Learning-Based Cervical Cancer Diagnosis and Prediction Model in Adjuvant Chemotherapy for Cervical Cancer\u202f: A Single-Center , Controlled , Non-Arbitrary Size Case-Control Study","first-page":"2022","author":"Wang","year":"2022"},{"key":"10.1016\/j.radi.2024.03.015_bib30","series-title":"Radiomic Machine Learning and External Validation Based on 3 . 0 T mpMRI for Prediction of Intraductal Carcinoma of Prostate With Different Proportion","first-page":"1","volume":"12","author":"Yang","year":"2022"},{"key":"10.1016\/j.radi.2024.03.015_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-022-04085-1","article-title":"Utility of serum biomarkers for predicting cancer in patients with previous neg,ative prostate biopsy","author":"Wang","year":"2022","journal-title":"World J Urol [Internet]"},{"issue":"8","key":"10.1016\/j.radi.2024.03.015_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.trecan.2019.06.006","article-title":"Integrating mathematical modeling into the roadmap for personalized adaptive radiation therapy","volume":"5","author":"Enderling","year":"2019","journal-title":"Trends Cancer"},{"issue":"10236","key":"10.1016\/j.radi.2024.03.015_bib33","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(20)30226-9","article-title":"Artificial intelligence and the future of global health","volume":"395","author":"Schwalbe","year":"2020","journal-title":"Lancet [Internet]"},{"key":"10.1016\/j.radi.2024.03.015_bib34","first-page":"10","article-title":"Feature selection via regularized trees","author":"Deng","year":"2012","journal-title":"Proceedings of the International Joint Conference on Neural Networks"},{"key":"10.1016\/j.radi.2024.03.015_bib35","first-page":"1","article-title":"Radiomics-based machine learning models for predicting P504s\/P63 immunohistochemical expression: a noninvasive diagnostic tool for prostate cancer","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.radi.2024.03.015_bib36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00259-020-04971-z","article-title":"Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer","volume":"48","author":"Cysouw","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.radi.2024.03.015_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/1550147720905234","article-title":"Random forest\u2013based feature selection and detection method for drunk driving recognition","volume":"16","author":"Li","year":"2020","journal-title":"Int J Distrib Sens Netw"},{"key":"10.1016\/j.radi.2024.03.015_bib38","first-page":"1","article-title":"PET\/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.radi.2024.03.015_bib39","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.prro.2020.04.014","article-title":"Triggered imaging with auto beam hold and pre-\/posttreatment CBCT during prostate SABR: analysis of time efficiency, target coverage, and normal volume changes","volume":"11","author":"Kisivan","year":"2021","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.radi.2024.03.015_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s13139-015-0390-9","article-title":"Correlation between apparent diffusion coefficients and standardized uptake values in hybrid 18F-FDG PET\/MR: preliminary results in rectal cancer","volume":"50","author":"Jeong","year":"2016","journal-title":"Nucl Med Mol Imaging [Internet]"},{"issue":"9","key":"10.1016\/j.radi.2024.03.015_bib41","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/0284185114549825","article-title":"Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDGPET\/ CT in pancreatic adenocarcinoma","volume":"56","author":"Sakane","year":"2015","journal-title":"Acta radiol"},{"issue":"3","key":"10.1016\/j.radi.2024.03.015_bib42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1148\/radiol.2353031338","article-title":"Apparent diffusion coefficient of human brain tumors at MR imaging","volume":"235","author":"Yamasaki","year":"2005","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.radi.2024.03.015_bib43","first-page":"1","article-title":"Multiparametric MRI in detection and staging of prostate cancer","volume":"64","author":"Boesen","year":"2017","journal-title":"Dan Med J"},{"issue":"4","key":"10.1016\/j.radi.2024.03.015_bib44","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.urology.2008.01.014","article-title":"Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng\/ml: a follow-up study","volume":"72","author":"Kumar","year":"2008","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.radi.2024.03.015_bib46","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1088\/0031-9155\/61\/9\/3504","article-title":"Whole-body hybrid imaging concept for the integration of PET\/MR into radiation therapy treatment planning","volume":"61","author":"Paulus","year":"2016","journal-title":"Phys Med Biol"},{"issue":"12","key":"10.1016\/j.radi.2024.03.015_bib47","doi-asserted-by":"crossref","first-page":"e853","DOI":"10.1016\/S2589-7500(22)00188-1","article-title":"Interpreting area under the receiver operating characteristic curve","volume":"4","author":"de Hond","year":"2022","journal-title":"Lancet Digit Health [Internet]"},{"issue":"3\/4","key":"10.1016\/j.radi.2024.03.015_bib48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2307\/2333709","article-title":"An Analysis of Variance Test for Normality (Complete Samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.radi.2024.03.015_bib49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.21037\/tau.2018.01.18","article-title":"Stereotactic ablative body radiotherapy in patients with prostate cancer","volume":"7","author":"Loblaw","year":"2018","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.radi.2024.03.015_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2022.02.007","article-title":"Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?","volume":"169","author":"Correa","year":"2022","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.radi.2024.03.015_bib51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00330-010-1999-9","article-title":"Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: Initial results","volume":"21","author":"Park","year":"2011","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.radi.2024.03.015_bib52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1470-2045(21)00705-1","article-title":"Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis","volume":"23","author":"Kishan","year":"2022","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.radi.2024.03.015_bib53","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.radi.2024.03.015_bib54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1148\/radiol.11091409","article-title":"Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer","volume":"259","author":"Hambrock","year":"2011","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.radi.2024.03.015_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.diii.2016.08.009","article-title":"Correlation between apparent diffusion coefficient value on diffusion-weighted MR imaging and Gleason score in prostate cancer","volume":"98","author":"Wu","year":"2017","journal-title":"Diagn Interv Imaging [Internet]"},{"key":"10.1016\/j.radi.2024.03.015_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.604266","article-title":"Prediction of pathological upgrading at radical prostatectomy in prostate cancer eligible for active surveillance: a texture features and machine learning-based analysis of apparent diffusion coefficient maps","volume":"10","author":"Xie","year":"2021","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.radi.2024.03.015_bib57","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.acra.2021.09.012","article-title":"Can pre-treatment quantitative multi-parametric MRI predict the outcome of radiotherapy in patients with prostate cancer?","volume":"29","author":"Chatterjee","year":"2022","journal-title":"Acad Radiol"},{"key":"10.1016\/j.radi.2024.03.015_bib59","doi-asserted-by":"crossref","first-page":"100530","DOI":"10.1016\/j.phro.2023.100530","article-title":"Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after radiation therapy","volume":"29","author":"Dutta","year":"2024","journal-title":"Phys Imaging Radiat Oncol [Internet]"},{"key":"10.1016\/j.radi.2024.03.015_bib58","first-page":"1","article-title":"Machine learning-based models enhance the prediction of prostate cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radi.2024.03.015_bib60","doi-asserted-by":"crossref","first-page":"779182","DOI":"10.3389\/fonc.2022.779182","article-title":"Dose-intensified stereotactic ablative radiation for localized prostate cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"}],"container-title":["Radiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078817424000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078817424000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T21:15:23Z","timestamp":1715721323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078817424000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1078817424000774"],"URL":"https:\/\/doi.org\/10.1016\/j.radi.2024.03.015","relation":{},"ISSN":["1078-8174"],"issn-type":[{"value":"1078-8174","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of magnetic resonance imaging diffusion parameters using artificial intelligence in low-and intermediate-risk prostate cancer patients treated with stereotactic ablative radiotherapy: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Radiography","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radi.2024.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of The College of Radiographers.","name":"copyright","label":"Copyright"}]}}